The European Medicines Agency has approved a phase 2 clinical trial for the Respiratory Syncytial Virus (RSV) vaccine, developed by Chilean researchers led by…
Dr. Alexis Kalergis, Director of the Millennium Institute of Immunology and Immunotherapy (MIII) and Full Professor in the Faculties of Biological Sciences and…
Published in one of the most prestigious medical journals globally, this is the first research that measures more than ten million people vaccinated under…
The world is frantically looking for a vaccine that will prevent infections of the novel coronavirus. Among the more than 100 research teams trying to develop…